Why is Onyx Biotec falling/rising?

As of 28-Oct, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 40.50, which represents a decrease of 2.0 or 4.71%. The stock has underperformed its sector by 4.45% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 5.81%, and in the last month, it has decreased by 9.90%. Despite a significant increase in delivery volume by 1364.29% against the 5-day average, there are no positive or negative factors available to provide further context on the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, which has increased by 0.26% over the past week and 5.20% over the past month, Onyx Biotec's performance has been notably poor. Year-to-date, while the Sensex has gained 9.69%, Onyx Biotec has seen a substantial decline of 31.93%. This stark contrast highlights the stock's struggles in the current market environment, indicating that investor sentiment may be leaning negatively towards the company despite the rising participation in trading.